| Inflammatory Bowel Disease | Lifetime | 17 | ES 1 | 99.87 |
| Microscopic Colitis | Lifetime | 20 | ES 2 | 99.81 |
| Diverticular Disease and Complications | Lifetime | 42 | ES 1 | 99.41 |
| Diagnosis and treatment of tuberculosis | Lifetime | 37 | ES 1 | 99.30 |
| Autoimmune and Inflammatory Disorders | Lifetime | 34 | ES 1 | 99.25 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 197 | ES 4 | 99.07 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 400 | ES 10 | 98.24 |
| Eosinophilic Esophagitis | Lifetime | 295 | ES 5 | 98.44 |
| Cell Adhesion Molecules Research | Lifetime | 580 | ES 8 | 98.22 |
| Liver Disease and Transplantation | Lifetime | 912 | ES 44 | 97.88 |
| Liver Diseases and Immunity | Lifetime | 291 | ES 9 | 97.71 |
| Anorectal Disease Treatments and Outcomes | Lifetime | 289 | ES 8 | 97.20 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 412 | ES 10 | 97.39 |
| Biosimilars and Bioanalytical Methods | Lifetime | 329 | ES 11 | 94.82 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 418 | ES 12 | 92.53 |
| Effects of Radiation Exposure | Lifetime | 597 | ES 4 | 94.66 |
| IL-33, ST2, and ILC Pathways | Lifetime | 651 | ES 6 | 94.28 |
| Gastrointestinal Bleeding Diagnosis and Treatment | Lifetime | 494 | ES 13 | 93.27 |
| Inflammation biomarkers and pathways | Lifetime | 996 | ES 31 | 67.64 |
| Inflammatory Bowel Disease | 2021-2025 | 16 | ES 1 | 99.77 |
| Microscopic Colitis | 2021-2025 | 23 | ES 1 | 99.58 |
| Diverticular Disease and Complications | 2021-2025 | 24 | ES 2 | 97.54 |
| Eosinophilic Esophagitis | 2021-2025 | 74 | ES 3 | 97.94 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 114 | ES 2 | 96.67 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 39 | ES 1 | 96.56 |
| Anorectal Disease Treatments and Outcomes | 2021-2025 | 139 | ES 4 | 92.70 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 527 | ES 24 | 94.83 |
| Liver Diseases and Immunity | 2021-2025 | 154 | ES 7 | 94.24 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 385 | ES 10 | 91.50 |
| Helicobacter pylori-related gastroenterology studies | 2021-2025 | 440 | ES 9 | 90.39 |
| Diagnosis and treatment of tuberculosis | 2021-2025 | 137 | ES 4 | 88.72 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 666 | ES 18 | 78.29 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 989 | ES 11 | 65.97 |
| Inflammation biomarkers and pathways | 2021-2025 | 591 | ES 17 | 26.76 |
